Susquehanna International Group
AQST icon

Susquehanna International Group’s Aquestive Therapeutics AQST Stock Holding History

Susquehanna International Group’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.33M Buy
321,300
+239,900
+295% +$974K ﹤0.01% 7178
2025
Q4 		$526K Sell
81,400
-171,100
-68% -$1.07M ﹤0.01% 8668
2025
Q3 		$1.41M Buy
252,500
+162,600
+181% +$703K ﹤0.01% 6528
2025
Q2 		$298K Buy
89,900
+44,100
+96% +$127K ﹤0.01% 10359
2025
Q1 		$133K Sell
45,800
-36,800
-45% -$111K ﹤0.01% 11320
2024
Q4 		$294K Sell
82,600
-64,600
-44% -$298K ﹤0.01% 9879
2024
Q3 		$733K Sell
147,200
-10,300
-7% -$40.1K ﹤0.01% 7544
2024
Q2 		$410K Sell
157,500
-165,300
-51% -$552K ﹤0.01% 8747
2024
Q1 		$1.38M Buy
322,800
+280,800
+669% +$935K ﹤0.01% 6199
2023
Q4 		$84.8K Buy
42,000
+29,600
+239% +$52.3K ﹤0.01% 11439
2023
Q3 		$19K Buy
+12,400
New +$21.3K ﹤0.01% 11617
2022
Q2 		– Sell
-73,500
Closed -$192K – 12819
2022
Q1 		$192K Sell
73,500
-111,200
-60% -$325K ﹤0.01% 11281
2021
Q4 		$718K Buy
184,700
+67,700
+58% +$340K ﹤0.01% 8176
2021
Q3 		$510K Buy
117,000
+36,400
+45% +$143K ﹤0.01% 9350
2021
Q2 		$320K Sell
80,600
-59,200
-42% -$236K ﹤0.01% 10632
2021
Q1 		$727K Buy
139,800
+75,100
+116% +$400K ﹤0.01% 8559
2020
Q4 		$346K Sell
64,700
-4,300
-6% -$25.8K ﹤0.01% 8985
2020
Q3 		$335K Sell
69,000
-12,500
-15% -$81.7K ﹤0.01% 8479
2020
Q2 		$396K Buy
+81,500
New +$375K ﹤0.01% 7838

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's AQST Position: Q1 2026 in Review

Susquehanna International Group reduced its Aquestive Therapeutics (AQST) stake by 43% in Q1 2026, selling an estimated $1.01M and leaving 337,635 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #7064.

Susquehanna International Group first reported a position in AQST in Q4 2019 and has held it in 23 quarters since. The position peaked at $6.09M in Q3 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Susquehanna International Group held 337,635 shares of Aquestive Therapeutics worth $1.4M as of Q1 2026.
  • Susquehanna International Group sold 249,614 Aquestive Therapeutics shares in Q1 2026, an estimated $1.01M.
  • Aquestive Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7064 holding.
  • Susquehanna International Group first reported a position in Aquestive Therapeutics in Q4 2019 and has held it in 23 quarters since.
  • Susquehanna International Group's Aquestive Therapeutics position peaked at $6.09M in Q3 2025.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.